ONO-4538 Study in Patients With Advanced Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2021-02-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to investigate the efficacy and safety of ONO-4538 in subjects
with stage IIIB/IV or recurrent non-small cell lung cancer unsuited to radical radiotherapy
and resistant to a platinum-based chemotherapeutic regimen.